Lack of Antinuclear Antibodies in Convalescent Coronavirus Disease 2019 Patients With Persistent Symptoms.
作者信息
Peluso Michael J, Thomas Isaac J, Munter Sadie E, Deeks Steven G, Henrich Timothy J
机构信息
Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco, California, USA.
Division of Experimental Medicine, University of California, San Francisco, California, USA.
出版信息
Clin Infect Dis. 2022 Jun 10;74(11):2083-2084. doi: 10.1093/cid/ciab890.
Abstract
摘要
相似文献
1
Lack of Antinuclear Antibodies in Convalescent Coronavirus Disease 2019 Patients With Persistent Symptoms.2019冠状病毒病康复期仍有持续症状患者缺乏抗核抗体
Clin Infect Dis. 2022 Jun 10;74(11):2083-2084. doi: 10.1093/cid/ciab890.
2
Antibody tests for identification of current and past infection with SARS-CoV-2.抗体检测用于鉴定 SARS-CoV-2 的现症感染和既往感染。
Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD013652. doi: 10.1002/14651858.CD013652.pub2.
3
The effect of early COVID-19 treatment with convalescent plasma on antibody responses to SARS-CoV-2.早期使用康复期血浆治疗新冠病毒病对严重急性呼吸综合征冠状病毒2抗体反应的影响。
Microbiol Spectr. 2025 Jul;13(7):e0300624. doi: 10.1128/spectrum.03006-24. Epub 2025 Jun 9.
4
Convalescent plasma for people with COVID-19: a living systematic review.COVID-19 患者恢复期血浆治疗：一项实时系统评价。
Cochrane Database Syst Rev. 2023 Feb 1;2(2):CD013600. doi: 10.1002/14651858.CD013600.pub5.
5
Convalescent plasma for people with COVID-19: a living systematic review.COVID-19 患者恢复期血浆治疗：一项实时系统评价。
Cochrane Database Syst Rev. 2023 May 10;5(5):CD013600. doi: 10.1002/14651858.CD013600.pub6.
6
SARS-CoV-2 Antibody Isotypes in Systemic Lupus Erythematosus Patients Prior to Vaccination: Associations With Disease Activity, Antinuclear Antibodies, and Immunomodulatory Drugs During the First Year of the Pandemic.SARS-CoV-2 抗体同种型在接种疫苗前的系统性红斑狼疮患者中的研究：在大流行的第一年与疾病活动度、抗核抗体和免疫调节药物的相关性。
Front Immunol. 2021 Aug 27;12:724047. doi: 10.3389/fimmu.2021.724047. eCollection 2021.
7
Humoral and Cellular Immune Responses to SARS-CoV-2 in Participants with Head and Neck Cancer.头颈癌患者对新型冠状病毒的体液免疫和细胞免疫反应
Viruses. 2025 Jun 13;17(6):848. doi: 10.3390/v17060848.
8
Viral and Immune Factors Associated With COVID-19 Outcome in the C3PO Trial of Convalescent Plasma.在恢复期血浆C3PO试验中与COVID-19预后相关的病毒和免疫因素
J Infect Dis. 2025 Jun 2;231(5):1198-1209. doi: 10.1093/infdis/jiaf109.
9
Endemic coronavirus infection is associated with SARS-CoV-2 Fc receptor-binding antibodies.地方性冠状病毒感染与严重急性呼吸综合征冠状病毒2（SARS-CoV-2）Fc受体结合抗体有关。
J Virol. 2025 Jun 17;99(6):e0055025. doi: 10.1128/jvi.00550-25. Epub 2025 May 19.
10
Gastrointestinal viral shedding in children with SARS-CoV-2: a systematic review and meta-analysis.儿童 SARS-CoV-2 胃肠道病毒脱落：系统评价和荟萃分析。
World J Pediatr. 2022 Sep;18(9):582-588. doi: 10.1007/s12519-022-00553-1. Epub 2022 Jun 4.
引用本文的文献
1
Distinct circulating autoantibodies are associated with COVID-19 hospitalization and SARS-CoV-2 neutralization activity.不同的循环自身抗体与COVID-19住院治疗及SARS-CoV-2中和活性相关。
Npj Viruses. 2025 Sep 2;3(1):64. doi: 10.1038/s44298-025-00149-2.
2
Autoantibodies directed against interferon alpha, nuclear antigens, cardiolipin, and beta 2 glycoprotein 1 are not induced by SARS-CoV-2 or associated with long COVID.针对干扰素α、核抗原、心磷脂和β2糖蛋白1的自身抗体不是由严重急性呼吸综合征冠状病毒2（SARS-CoV-2）诱导产生的，也与新冠后综合征无关。
Int J Infect Dis. 2025 Jan;150:107289. doi: 10.1016/j.ijid.2024.107289. Epub 2024 Nov 1.
3
Mechanisms of long COVID and the path toward therapeutics.长新冠的发病机制和治疗方法研究进展。
Cell. 2024 Oct 3;187(20):5500-5529. doi: 10.1016/j.cell.2024.07.054. Epub 2024 Sep 25.
4
Mechanisms of long COVID: An updated review.长新冠的发病机制：最新综述
Chin Med J Pulm Crit Care Med. 2023 Dec 6;1(4):231-240. doi: 10.1016/j.pccm.2023.10.003. eCollection 2023 Dec.
5
Laboratory Findings and Biomarkers in Long COVID: What Do We Know So Far? Insights into Epidemiology, Pathogenesis, Therapeutic Perspectives and Challenges.长新冠的实验室发现和生物标志物：目前我们了解多少？对流行病学、发病机制、治疗前景和挑战的洞察。
Int J Mol Sci. 2023 Jun 21;24(13):10458. doi: 10.3390/ijms241310458.
6
Autoantigen profiling reveals a shared post-COVID signature in fully recovered and long COVID patients.自身抗原分析揭示了完全康复和长新冠患者的共享新冠后特征。
JCI Insight. 2023 Jun 8;8(11):e169515. doi: 10.1172/jci.insight.169515.
7
Immune mechanisms underlying COVID-19 pathology and post-acute sequelae of SARS-CoV-2 infection (PASC).COVID-19 病理学和 SARS-CoV-2 感染后后遗症（PASC）的免疫机制。
Elife. 2023 May 26;12:e86014. doi: 10.7554/eLife.86014.
8
Long COVID in people living with HIV.HIV 感染者的长新冠。
Curr Opin HIV AIDS. 2023 May 1;18(3):126-134. doi: 10.1097/COH.0000000000000789. Epub 2023 Mar 20.
9
Characterizing and Predicting Post-Acute Sequelae of SARS CoV-2 Infection (PASC) in a Large Academic Medical Center in the US.美国一家大型学术医疗中心对新冠病毒感染后急性后遗症（PASC）的特征描述与预测
J Clin Med. 2023 Feb 7;12(4):1328. doi: 10.3390/jcm12041328.
10
Autoantigen profiling reveals a shared post-COVID signature in fully recovered and Long COVID patients.自身抗原分析揭示了完全康复的新冠患者和长期新冠患者中存在的共同特征。
medRxiv. 2023 Feb 9:2023.02.06.23285532. doi: 10.1101/2023.02.06.23285532.
本文引用的文献
1
Persistent Symptoms in Adult Patients 1 Year After Coronavirus Disease 2019 (COVID-19): A Prospective Cohort Study.新冠肺炎（COVID-19）痊愈 1 年后成人患者的持续性症状：一项前瞻性队列研究。
Clin Infect Dis. 2022 Apr 9;74(7):1191-1198. doi: 10.1093/cid/ciab611.
2
Functional autoantibodies against G-protein coupled receptors in patients with persistent Long-COVID-19 symptoms.患有持续性长新冠症状患者体内针对G蛋白偶联受体的功能性自身抗体。
J Transl Autoimmun. 2021;4:100100. doi: 10.1016/j.jtauto.2021.100100. Epub 2021 Apr 16.
3
SARS-CoV-2 infection as a trigger of autoimmune response.新型冠状病毒2型感染作为自身免疫反应的触发因素。
Clin Transl Sci. 2021 May;14(3):898-907. doi: 10.1111/cts.12953. Epub 2021 Jan 21.
4
Immune-mediated neurological syndromes in SARS-CoV-2-infected patients.感染 SARS-CoV-2 患者的免疫介导性神经系统综合征。
J Neurol. 2021 Mar;268(3):751-757. doi: 10.1007/s00415-020-10108-x. Epub 2020 Jul 30.
5
Range of antinuclear antibodies in "healthy" individuals.“健康”个体中抗核抗体的范围。
Arthritis Rheum. 1997 Sep;40(9):1601-11. doi: 10.1002/art.1780400909.
Zotero 插件